Modifying pirfenidone treatment for patients with atypical liver function
US7566729B1 · kind B1 · utility
13Cited by
4References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 22, 2009 |
| Grant date | Jul 28, 2009 |
| Priority date | — |
| Expiry date | Apr 22, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods are provided for administering pirfenidone to a patient that has exhibited abnormal biomarkers of liver function in response to pirfenidone administration. The methods include administering to a patient pirfenidone at doses lower than the full target dosage for a time period, followed by administering to the patient pirfenidone at the full target dosage.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.